Clinical Trial: Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba

Share this article:
Clinical Trial: Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba

Sponsor and Collaborators

University of Manitoba
Canadian Institutes of Health Research (CIHR)
CancerCare Manitoba

Contact
Contact: Kathleen M Clouston, Ph.D.
204-272-3086
kclousto@cc.umanitoba.ca

Contact: Alan Katz, MBChB, CCFP, MSc
204-789-3442
katz@cc.umanitoba.ca

Principal Investigator
Principal Investigator: Alan Katz, MBChB, CCFP, MSc University of Manitoba
Study Director: Kathleen M Clouston, Ph.D. University of Manitoba

ClinicalTrials.gov Identifier
NCT01026753
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Colorectal Cancer Clinical Trials

Clinical Trial: Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative ...

Clinical trial focusing on 5-FU for colorectal patients. Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety (IOCCRC)

Clinical Trial: Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC)

Clinical trial focusing on biomarker analysis and metastatic colorectal cancer. Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC)

Clinical Trial: Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational ...

Clinical trial focusing on biomarker analysis for translational integration in colorectal cancer. Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer (ACROBATICC)